Certara Inc
(NAS:CERT)
$
11.21
0.55 (5.16%)
Market Cap: 1.80 Bil
Enterprise Value: 1.88 Bil
PE Ratio: 0
PB Ratio: 1.71
GF Score: 74/100 Certara Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 14, 2021 / 01:30PM GMT
Release Date Price:
$33.92
(-6.25%)
Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst
Great. Thank you, everyone, for joining. Let's go ahead and get started. My name is Vikram Purohit. I'm one of the biotech research analysts with Morgan Stanley. I'm very happy to have with me Bill Feehery and Andy Schemick, CEO and CFO of Certara. Bill and Andy, thank you for joining us. Appreciate your time.
William F. Feehery
Certara, Inc. - CEO & Director
Thanks, Vikram. It's great to be here.
Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst
Yes. And before we go ahead and get started, I just need to read a brief disclosure. So for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.
So with that, let's go ahead and get started. Actually, one more note for the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot